Palliative treatment of colorectal cancer in Germany: Cost of care and quality of life

European Journal of Health Economics

Volumn 14, Issue 4, 2013, Pages 629-638

  Emmert, Martin ^a   Pohl Dernick, Katharina ^a   Wein, Axel ^a   Dörje, Frank ^b   Merkel, Susanne ^a   Boxberger, Frank ^a   Männlein, Gudrun ^a   Joost, Robert ^b   Harich, Hans Detlev ^c   Thiemann, Roland ^d   Lamberti, Christof ^e   Neurath, Markus F ^a   Hohenberger, Werner ^a   Schöffski, Oliver ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c Friedrich Alexander University ^*  (Germany)

^d Practice for Oncology   (Germany)

^e KLINIKUM COBURG   (Germany)

Author keywords

Colorectal cancer; Cost of care; Health service research; Palliative care; Quality of life; SF 12

Indexed keywords

ADULT; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ECONOMIC EVALUATION; FEMALE; GERMANY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; REIMBURSEMENT; SCORING SYSTEM; SHORT FORM 12; TRAFFIC AND TRANSPORT;

AGED; COLORECTAL NEOPLASMS; FEMALE; GERMANY; HEALTH CARE COSTS; HUMANS; MALE; PALLIATIVE CARE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84879927473     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-012-0408-5     Document Type: Article

References (54)

1. Robert Koch-Institut: Sterblichkeit, Todesursachen und regionale Unterschiede. Heft 52. Gesundheitsberichtserstattung des Bundes, Berlin (2011)
2. Robert Koch-Institut: Gesellschaft der epidemiologischen Krebsregister in Deutschland: Krebs in Deutschland 2005/2006: Häufigkeiten und Trends. Gesundheitsberichterstattung des Bundes, Berlin (2010)
3. Boyle, P.; Ferlay, J.: Cancer incidence and mortality in Europe, 2004. Ann. Oncol. 16, 481-488 (2005)
4. Clerc, L.; Jooste, V.; Lejeune, C.; Schmitt, B.; Arveux, P.; Quantin, C.; Faivre, J.; Bouvier, A.M.: Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France. Eur. J. Health Econom. 9, 361-367 (2008)
5. Statistisches Bundesamt: Total Cost of Illness in millions of Euro. Classification: years, gender, ICD10, provider (2010)
6. Jansman, F.G.; Postma, M.J.; Brouwers, J.R.: Cost considerations in the treatment of colorectal cancer. Pharmacoeconomics 25, 537-562 (2007)
7. Lopatriello, S.; Amoroso, D.; Donati, S.; Alabiso, O.; Forti, L.; Fornasiero, A.; Smergo, A.; Lalli, A.; Iacono, C.; Lucenti, A.; D'Alonzo, L.; Negrini, C.: The CAP-CR study: direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabine. Eur. J. Cancer 44, 2615-2622 (2008)
8. Com-Ruelle, L.; Lucas-Gabrielli, V.; Renaud, T.: Le coût du cancer du côlon en Ile-de-France: questions d'économie de la santé. Bulletin d'information en économie de la santé No 98. Institut de recherche et documentation en économie de la santé (2005)
9. Warren, J.; Yabroff, K.; Meekins, A.; Topor, M.; Lamont, E.; Brown, M.: Evaluation of trends in the cost of initial cancer treatment. J. Natl Cancer Inst. 100, 888-897 (2008)
10. Delcò, F.; Egger, R.; Bauerfeind, P.; Beglinger, C.: Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland. Aliment. Pharmacol. Ther. 21, 615-622 (2005)
11. Choi, K.S.; Park, E.; Lim, M.; Lim, J.; Kim, S.; Park, J.H.; Jeong, S.; Park, J.W.; Lim, S.; Choi, H.S.; Jung, K.H.; Kim, D.Y.; Park, J.: Cost of colorectal cancer care in Korea: a prospective group study with a 2-year follow-up. J. Korean Soc. Coloproctol. 24, 357-366 (2008)
12. Tilson, L.; Sharp, L.; Usher, C.; Walsh, C.; Whyte, S.; O'Ceilleachair, A.; Stuart, C.; Mehigan, B.; John Kennedy, M.; Tappenden, P.; Chilcott, J.; Staines, A.; Comber, H.; Barry, M.: Cost of care for colorectal cancer in Ireland: a health care payer perspective. Eur. J. Health Econom. (2011). doi: 10.1007/s10198-011-0325-z
13. Schmiegel, W.; Pox, C.; Reinacher-Schick, A.; Adler, G.; Arnold, D.; Fleig, W.; Fölsch, U.R.; Frühmorgen, P.; Graeven, U.; Heinemann, V.; Hohenberger, W.; Holstege, A.; Junginger, T.; Kopp, I.; Kühlbacher, T.; Porschen, R.; Propping, P.; Riemann, J.; Rödel, C.; Sauer, R.; Sauerbruch, T.; Schmitt, W.; Schmoll, H.; Seufferlein, T.; Zeitz, M.; Selbman, H.: S3 guidelines for colorectal carcinoma: S3-Leitlinie "Kolorektales Karzinom". Z. Gastroenterol. 48, 65-136 (2010)
14. Schmiegel, W.; Reinacher-Schick, A.; Arnold, D.; Graeven, U.; Heinemann, V.; Porschen, R.; Riemann, J.; Rödel, C.; Sauer, R.; Wieser, M.; Schmitt, W.; Schmoll, H.; Seufferlein, T.; Kopp, I.; Pox, C.: Update S3-guideline "Colorectal Cancer" 2008: S3-Leitlinie "Kolorektales Karzinom" Aktualisierung 2008. Z. Gastroenterol. 46, 799-840 (2008)
15. Lejeune, C.; Binquet, C.; Bonnetain, F.; Mahboubi, A.; Abrahamowicz, M.; Moreau, T.; Raikou, M.; Bedenne, L.; Quantin, C.; Bonithon-Kopp, C.: Estimating the cost related to surveillance of colorectal cancer in a French population. Eur. J. Health Econom. 10, 409-419 (2009)
16. American Joint Committee on Cancer: Colon and Rectum Cancer Staging. http://www.cancerstaging.org/staging/posters/colon8.5x11.pdf (2009). Accessed 11 Jan 2012
17. Sobin, L.H.; Gospodarowicz, M.K.; Wittekind, C.: TNM Classification Of Malignant Tumours. Wiley-Blackwell, Chichester (2009)
18. American Cancer Society: Colorectal cancer: what is cancer? http://www.cancer.org/acs/groups/cid/documents/webcontent/003096-pdf.pdf (2011). Accessed 11 Jan 2012
19. Bundesministerium für Gesundheit: Gesetzliche Krankenversicherung: Kennzahlen und Faustformeln (2010)
20. Kassenärztliche Bundesvereinigung: Einheitlicher Bewertungsmaßstab (EBM): Stand: 4. Quartal 2011. Berlin (2010)
21. Görner, M.; Riemer-Hommel, P.: Adjuvant chemotherapy for colon cancer-analysis of treatment costs from the perspective of statutory sickness funds. Z. Gastroenterol. 46, 681-688 (2008)
22. InEK - Institut für das Entgeltsystem im Krankenhaus: Fallpauschalen-Katalog 2011: G-DRG-Version 2011. Siegburg (2010)
23. Müller-Riemenschneider, F.; Damm, K.; Meinard, C.; Bockelbrink, A.; Vauth, C.; Willich, S.; Greiner, G.: Nichmedikamentöse Sekundä rprävention der koronaren Herzkrankheit (KHK). HTA-Bericht 95. Deutsche Agentur für Health Technology Assessment, Köln (2009)
24. Drummond, M.; Jefferson, T.O.: Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 313, 275-283 (1996)
25. Ware, J.E. Jr.; Turner-Bowker, D.M.; Gandek, N.K.: User's manual for the SF-12v2 health survey with a supplement documenting SF-12 health survey. Quality Metric Incorporated, Lincoln, RI (2002)
26. Bullinger, M.; Schmidt, S.: Methoden zur Lebensqualitätsbewertung in der Onkologie. In: Schmoll, HJ.; Höffken, K.; Possinger, K. (eds.) Kompendium Internistische Onkologie. Standards in Diagnostik und Therapie, pp. 2505-2516. Springer, Heidelberg (2006)
27. Gandek, B.; Ware, J.; Aaronson, N.; Apolone, G.; Bjorner, J.; Brazier, J.; Bullinger, M.; Kaasa, S.; Leplege, A.; Prieto, L.; Sullivan, M.: Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project. J. Clin. Epidemiol. 11, 1171-1178 (1998)
28. Bullinger, M.; Kirchberger, I.: SF-36. Fragebogen zum Gesundheitszustand. Handanweisung. Hogrefe, Göttingen (1998)
29. Dijkers, M.: Correlates of life satisfaction among people with spinal cord injury. Arch. Phys. Med. Rehabil. 8, 867-876 (1999)
30. Lin, M.R.; Hwang, H.F.; Chen, C.Y.; Chiu, W.T.: Comparisons of the brief form of the World Health Organization Quality of Life and Short Form-36 for persons with spinal cord injuries. Am. J. Phys. Med. Rehabil. 86, 104-113 (2007)
31. Hill, M.R.; Noonan, V.K.; Sakakibara, B.M.; Miller, W.C.: Quality of life instruments and definitions in individuals with spinal cord injury: a systematic review. Spinal Cord 48, 438-450 (2010)
32. Delgado-Sanz, M.C.; García-Mendizábal, M.J.; Pollán, M.; Forjaz, M.J.; López-Abente, G.; Aragonés, N.; Pérez-Gómez, B.: Heath-related quality of life in Spanish breast cancer patients: a systematic review. Health Qual. Life Outcomes. (2011). doi: 10.1186/1477-7525-9-3
33. Grozdev, I.; Kast, D.; Cao, L.; Carlson, D.; Pujari, P.; Schmotzer, B.; Babineau, D.; Ker, E.; McCormick, T.; Cooper, K.D.; Korman, N.J.: Physical and mental impact of psoriasis severity as measured by the compact short form-12 health survey (SF-12) Quality of Life Tool. J. Invest. Dermatol. (2011). doi: 10.1038/jid.2011.427
34. Nagel, S.N.; Teichgräber, U.K.M.; Kausche, S.; Lehmann, A.: Satisfaction and quality of life: a survey-based assessment in patients with a totally implantable venous port system. Eur. J. Cancer Care. (2011). doi: 10.1111/j.1365-2354.2011.01275.x
35. Schunk, M.; Reitmeir, P.; Schipf, S.; Völzke, H.; Meisinger, C.; Thorand, B.; Kluttig, A.; Greiser, KH.; Berger, K.; Müller, G.; Ellert, U.; Heuhauser, H.; Tamayo, T.; Rathmann, W.; Holle, R.: Health-related quality of life in subjects with and without Type 2 diabetes: pooled analysis of five population-based surveys in Germany. Diabetic Med. (2011). doi: 10.1111/j.1464-5491.2011.03465.x. (Accepted Article)
36. Nickel, S.; Thiedemann, B.; von dem Knesebeck, O.: The effects of integrated inpatient health care on patient satisfaction and health-related quality of life: results of a survey among heart disease patients in Germany. Health Policy 2-3, 156-163 (2010)
37. König, H.; Heider, D.; Lehnert, T.; Riedel-Heller, S.; Angermeyer, C.; Matschinger, H.; Vilagut, G.; Bruffaerts, R.; Haro, J.; de Girolamo, G.; de Graaf, R.; Kovess, V.; Jordi, A.: Health status of the advanced elderly in six European countries: results from a representative survey using EQ-5D and SF-12. Health Qual. Life Outcomes (2010). doi: 10.1186/1477-7525-8-143
38. Bruns, H.; Krätschmer, K.; Hinz, U.; Brechtel, A.; Keller, M.; Bücheler, M.; Schemmer, P.: Quality of life after curative liver resection: a single center analysis. World J. Gastroenterol. 16, 2388-2395 (2010)
39. Müller-Nordhorn, J.; Roll, S.; Willich, S.N.: Comparison of the short form (SF)-12 health status instrument with the SF-36 in patients with coronary heart disease. Heart 90, 523-527 (2004)
40. Schmidt, A.; Bramlage, P.; Limberg, R.; Kreutz, R.: Quality of life in hypertension management using olmesartan in primary care. Expert Opin. Pharmacother. 9, 1641-1653 (2008)
41. Müller-Nordhorn, J.; Nolte, C.; Rossnagel, K.; Jungehülsing, G.; Reich, A.; Roll, S.; Villringer, A.; Willich, S.: The use of the 12-item short-form health status instrument in a longitudinal study of patients with stroke and ransient ischaemic attack. Neuroepidemiology 24, 196-202 (2005)
42. Watkins, D.J.; Chau, I.; Cunningham, D.; Mudan, S.S.; Karanjia, N.; Brown, G.; Ashley, S.; Norman, A.R.; Gillbanks, A.: Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status. Br. J. Cancer 102, 255-261 (2010)
43. Wein, A.; Riedel, C.; Brückl, W.; Merkel, S.; Ott, R.; Hanke, B.; Baum, U.; Fuchs, F.; Günther, K.; Reck, T.; Papadopoulos, T.; Hahn, E.G.; Hohenberger, W.: Neoadjuvant treatment with weekly high-dose 5-fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer. Oncology 64, 131-138 (2003)
44. Wein, A.; Riedel, C.; Köckerling, F.; Martus, P.; Baum, U.; Brueckl, W.M.; Reck, T.; Ott, R.; Hänsler, J.; Bernatik, T.; Becker, D.; Schneider, T.; Hohenberger, W.; Hahn, E.G.: Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid. Ann. Oncol. 12, 1721-1727 (2001)
45. Carlson, J.J.; Sullivan, S.D.; Garrison, L.P.; Neumann, P.J.; Veenstra, D.L.: Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health Policy 96, 179-190 (2010)
46. van Herck, P.; De Smedt, D.; Annemans, L.; Remmen, R.; Rosenthal, M.B.; Sermeus, W.: Systematic review: effects, design choices, and context of pay-for-performance in health care. BMC Health Serv. Res. 10, 247 (2010)
47. Christianson, J.B.; Leatherman, S.; Sutherland, K.: Lessons from evaluations of purchaser pay-for-performance programs a review of the evidence. Med. Care Res. Rev. 65, 5S-35S (2008)
48. Fung, C.H.; Lim, Y.W.; Mattke, S.; Damberg, C.; Shekelle, P.G.: Systematic review: the evidence that publishing patient care performance data improves quality of care. Ann. Intern. Med. 148, 111-123 (2008)
49. Flodgren, G.; Eccles, M.P.; Shepperd, S.; Scott, A.; Parmelli, E.; Beyer, F.R.: An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database Syst. Rev. 7, CD009255 (2011)
50. Eijkenaar, F.: Key issues in the design of pay for performance programs. Eur. J. Health Econom. (2011). doi: 10.1007/s10198-011-0347-6
51. Rhoads, K.F.; Konety, B.M.; Dudley, R.A.: Performance measurement, public reporting, and pay-for-performance. Urol. Clin. North Am. 36, 37-48, vi (2009)
52. Rosenthal, M.B.; Landon, B.E.; Howitt, K.; Song, H.R.; Epstein, A.M.: Climbing up the pay-for-performance learning curve: where are the early adopters now? Health Aff. 26, 1674-1682 (2007)
53. Emmert, M.; Eijkenaar, F.; Kemter, H.; Esslinger, AS.; Schöffski, O.: Economic evaluation of pay-for-performance in health care: a systematic review. Eur. J. Health Econom. (2011). doi: 10.1007/s10198-011-0329-8
54. Wheeler, J.R.; White, B.; Rauscher, S.; Nahre, T.A.; Reiter, K.L.; Curtin, K.M.; Damberg, C.L.: Pay-for-performance as a method to establish the business case for quality. J. Health Care Finance 33, 17-30 (2007)